R&G PharmaStudies Co., Ltd. (SHE:301333)
67.63
-0.99 (-1.44%)
At close: Apr 21, 2026
R&G PharmaStudies Employees
R&G PharmaStudies had 2,208 employees as of December 31, 2024. The number of employees increased by 166 or 8.13% compared to the previous year.
Employees
2,208
Change (1Y)
166
Growth (1Y)
8.13%
Revenue / Employee
1.06M CNY
Profits / Employee
171.12K CNY
Market Cap
6.49B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2,208 | 166 | 8.13% |
| Dec 31, 2023 | 2,042 | 116 | 6.02% |
| Jan 1, 2023 | 1,926 | 1,298 | 206.69% |
| Dec 31, 2015 | 628 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Xiangxue Pharmaceutical | 2,769 |
| Anhui Huaheng Biotechnology | 2,252 |
| Novogene | 2,190 |
| Kexing Biopharm | 971 |
| Wuhan Keqian Biology Co.,Ltd | 922 |
| Shenzhen Weiguang Biological Products | 859 |
| Beijing Konruns Pharmaceutical | 668 |
| Innovita Biological Technology | 558 |